Physician profile
Caroline Friedman
NPI 1487071502
$1,090.30
in general payments reported to CMS, 2019-2025
15 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $68.40 · 2021: $199 · 2022: $44.25 · 2023: $187 · 2024: $230 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $203.62 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Evofem Biosciences, INC. | $167.31 | 2021-2025 | Phexxi, Solosec, Phexx |
| Shield Therapeutics INC | $144.88 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $104.22 | 2023-2024 | |
| Biogen, INC. | $73.32 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $70.13 | 2020-2021 | |
| Organon LLC | $66.31 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $57.00 | 2025 | Veozah |
| Sanofi Pasteur INC. | $53.91 | 2024-2025 | |
| Exeltis, USA INC. | $42.77 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $25.16 | 2023 | |
| Daiichi Sankyo INC. | $23.92 | 2020 | |
| Scynexis, INC. | $20.80 | 2022 | |
| Merck Sharp & Dohme LLC | $19.13 | 2021 | |
| Abbvie INC. | $17.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.